Help us: Donate
Follow us on:
Γ—

Menu

Back

Dorian Therapeutics

Organization Description

Dorian Therapeutics is a company developing senoblockers, a new class of therapeutics that can rejuvenate cells and tissues. Based on a patented technology developed at Stanford University, Dorian’s team is bringing to the clinic an innovative solution for age-associated diseases.

Team

Maddalena Adorno, Ph.D.

Dorian Therapeutics - CEO